Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 243,592 | 225,449 | 175,380 | 114,821 | 207,566 |
| Receivables | 210,214 | 213,908 | 202,658 | 171,259 | 201,794 |
| Inventories | 96,882 | 88,023 | 72,362 | 65,128 | 61,914 |
| Other current assets | 67,451 | 80,484 | 50,693 | 68,114 | 39,032 |
| TOTAL | $618,139 | $607,864 | $501,093 | $419,322 | $510,306 |
| Non-Current Assets | |||||
| PPE Net | 837,246 | 748,793 | 534,745 | 387,501 | 357,149 |
| Intangibles | 593,678 | 1,269,445 | 1,279,513 | 1,272,611 | 1,678,880 |
| Other Non-Current Assets | 92,350 | 179,435 | 242,193 | 458,775 | 80,500 |
| TOTAL | $1,523,274 | $2,197,673 | $2,056,451 | $2,118,887 | $2,116,529 |
| Total Assets | $2,141,413 | $2,805,537 | $2,557,544 | $2,538,209 | $2,626,835 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 35,452 | 25,051 | 24,970 | 36,263 | 80,865 |
| Accounts payable and accrued liabilities | 40,517 | 36,715 | 28,223 | 28,727 | 28,672 |
| Accrued Expenses | 115,611 | 114,725 | 83,642 | 76,863 | 97,759 |
| Other current liabilities | 22,711 | 23,268 | 25,632 | 43,581 | 24,329 |
| TOTAL | $300,998 | $302,528 | $259,331 | $311,412 | $349,115 |
| Non-Current Liabilities | |||||
| Long Term Debt | 479,880 | 484,998 | 547,084 | 259,902 | 605,980 |
| Deferred Revenues | 86,707 | 102,021 | 93,197 | 95,564 | 117,490 |
| aiOther Non-Current Liabilities | 119,514 | 157,074 | 155,918 | 139,882 | 199,235 |
| TOTAL | $598,707 | $642,542 | $703,002 | $399,784 | $805,215 |
| Total Liabilities | $899,705 | $945,070 | $962,333 | $711,196 | $1,154,330 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,790 | 68,176 | 66,933 | 71,992 | 66,110 |
| Common Shares | 766 | 754 | 734 | 724 | 658 |
| Retained earnings | -352,934 | 177,529 | 23,123 | 78,906 | -63,093 |
| Other shareholders' equity | 3,845 | 85,187 | 21,216 | -12,242 | 16,086 |
| TOTAL | $1,241,708 | $1,860,467 | $1,595,211 | $1,827,013 | $1,472,505 |
| Total Liabilities And Equity | $2,141,413 | $2,805,537 | $2,557,544 | $2,538,209 | $2,626,835 |